2043-2862 Screening compound: 2-ethoxy-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]benzamide

2043-2862 Screening compound: 2-ethoxy-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]benzamide
2043-2862 Screening compound: 2-ethoxy-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2043-2862
2-ethoxy-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2043-2862

Molecular Formula

C19H18N2O2S (C19 H18 N2 O2 S)

Compound Name

2-ethoxy-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]benzamide

IUPAC name

2-ethoxy-N-[4-(4-methylphenyl)-13-thiazol-2-yl]benzamide

SMILES

CCOc(cccc1)c1C(Nc1nc(-c2ccc(C)cc2)cs1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

338.43

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.341

Distribution Coefficient, logD

5.329

Water Solubility, LogSw

-5.23

Polar Surface Area

40.315

Acid Dissociation Constant (pKa)

8.96

Base Dissociation Constant (pKb)

0.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.80

2043-2862 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epigenetics Focused Set (26518 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 2043-2862 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2043-2862?
Check Price and Availability of 2043-2862, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2043-2862 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2043-2862
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2043-2862
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2043-2862 available by request